oncology
Opinion: Balancing Risks and Rewards of CAR T-Cell Therapy
Opinion: Balancing Risks and Rewards of CAR T-Cell Therapy
David Harris | Dec 15, 2016
New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.
Pfizer to Buy Medivation for $14 Billion
Pfizer to Buy Medivation for $14 Billion
Bob Grant | Aug 22, 2016
The pharma giant is purchasing the San Francisco–based cancer drugmaker to boost its oncology portfolio.
Renowned Cancer Theorist Dies
Renowned Cancer Theorist Dies
Alison F. Takemura | Jul 12, 2016
Alfred Knudson, who formulated the “two-hit” theory on the origins of cancer, has passed away at age 93.
New FDA Center Aims to Expedite Cancer Treatment Reviews
New FDA Center Aims to Expedite Cancer Treatment Reviews
Alison F. Takemura | Jun 30, 2016
The Oncology Center of Excellence, a product of the White House’s Cancer Moonshot initiative, will bring together oncologists across the US Food and Drug Administration.
Thirumala-Devi Kanneganti: Immersed in Immunology
Thirumala-Devi Kanneganti: Immersed in Immunology
Karen Zusi | Jun 1, 2016
Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43
AACR Q&A: Angelika Amon
AACR Q&A: Angelika Amon
The Scientist Staff | Apr 19, 2016
The aneuploidy expert shares what she has learned at the American Association for Cancer Research annual meeting.
Antioxidants Again Linked to Cancer’s Spread
Antioxidants Again Linked to Cancer’s Spread
Anna Azvolinsky | Apr 13, 2016
Certain diabetes drugs with antioxidant properties promote metastasis in mice with existing tumors, researchers report.
Tumor Traps
Tumor Traps
Kerry Grens | Apr 1, 2016
After surgery to remove a tumor, neutrophils recruited to the site spit out sticky webs of DNA that aid cancer recurrence.
Cancer's Vanguard
Cancer's Vanguard
Catherine Offord | Apr 1, 2016
Exosomes are emerging as key players in metastasis.
Tumor-Shrinking Triple-Helices
Tumor-Shrinking Triple-Helices
Ruth Williams | Apr 1, 2016
A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.